About 300 reports

  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H2 2017
  • PTX-15 - DRUG PROFILE

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Device
  • Targeted Therapy
  • Transplantation
  • Vaccine
  • HEART TRANSPLANT REJECTION - PIPELINE BY HEAT BIOLOGICS INC, H1 2018
  • HEART TRANSPLANT REJECTION - PIPELINE BY NOXXON PHARMA AG, H1 2018

Heart transplant replaces an injured or diseased heart with a healthy one.

  • Heart Transplant
  • Medical Biotechnology
  • Targeted Therapy
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2017*

HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* CLINICAL TRIALS BY END POINT STATUS HEART TRANSPLANT REJECTION THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2017* HEART TRANSPLANT REJECTION

  • Clinical Trial
  • Immunology
  • Medical Device
  • Targeted Therapy
  • Vaccine

Autograft A transplant of tissue from one to oneself.

  • Immunology
  • Medical Device
  • Targeted Therapy
  • Transplantation
  • Vaccine
  • DEFINITY - Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Cardiac Transplant Patients: RTMPE for CAV
  • Recruiting

Heart failure is associated with changes in the cardiac sympathetic nerve function.

  • Medical Device
  • United States
  • World
  • Company
  • Lantheus Medical Imaging, Inc.

More than ##% of US heart transplant centers are now using the guidelinerecommended AlloMap for heart transplant patient surveillance.

  • Medical Device
  • Molecular Diagnostics
  • Prosthesis
  • Vaccine
  • CareDx, Inc.
  • MAGNETOM AVANTO 1.5T TIM+DOT INTEGRATED - MAGNETIC RESONANCE ELASTOGRAPHY OF CARDIAC TRANSPLANT REJECTION
  • MAGNETOM AVANTO 1.5T TIM+DOT INTEGRATED - ASSESSMENT OF BRONCHIAL THICKNESS USING MRII IN ASTHMA

Features that Salinas Valley Memorial Hospital is uniquely leveraging include: Enhanced cardiac workflow: Multi-echo T## Mapping takes cardiac workflow one step further.

  • Immunology
  • Medical Device
  • Orthopedics
  • Targeted Therapy
  • Vaccine

WE ARE FULFILLING OUR PROMISE TO MAKE SEQUENCING BASED INFORMATION AVAILABLE TO THE TRANSPLANT CLINIC, NOW ALSO FOR HEART TRANSPLANT PATIENTS. "

  • Medical Device
  • Orthopedics
  • Vaccine
  • Canada
  • North America

He has developed one of the largest and most reputable transplant programs in the world.

  • Immunology
  • Medical Device
  • Transplantation
  • United States
  • Transplant Genomics Inc.
  • EMERGENCE OF TAH
  • COMPARISON BY PRODUCT

The number of patients with end-stage heart failure awaiting heart transplantation exceeds the number of hearts available for transplant.

  • Immunology
  • Medical Device
  • Vaccine
  • Baxter International Inc.
  • Boston Scientific Corporation
  • HEART PUMP DEVICES MARKET FOR BRIDGE-TO-TRANSPLANT THERAPY, BY REGION, 2015-2022 (USD MILLION)
  • Year

Heart transplantation is the most effective way to treat cardiac failure.

  • Medical Device
  • Vaccine
  • North America
  • United States
  • Abiomed, Inc.
  • MAGNETOM AVANTO 1.5T TIM+DOT INTEGRATED - MAGNETIC RESONANCE ELASTOGRAPHY OF CARDIAC TRANSPLANT REJECTION
  • MAGNETOM AVANTO 1.5T TIM+DOT INTEGRATED - ASSESSMENT OF BRONCHIAL THICKNESS USING MRII IN ASTHMA

One year after the patients cardiac arrests, the researchers assessed survivors with the Cerebral Performance Category (CPC) Scale, a commonly used measure of neurological function following cardiac arrest.

  • Immunology
  • Medical Device
  • Orthopedics
  • Targeted Therapy
  • Vaccine

Food and Drug Administration (FDA), World Health Organization (WHO), GLOBOCAN, and various organ transplant registries.

  • Medical Device
  • Orthopedics
  • North America
  • United States
  • Zimmer Biomet Holdings, Inc.

Liver transplant replaces an injured or diseased liver with a healthy one.

  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Targeted Therapy
  • Transplantation
  • Vaccine
  • SYNCARDIA 50CC TEMPORARY TOTAL ARTIFICIAL HEART - DESTINATION THERAPY - PRODUCT DESCRIPTION
  • SYNCARDIA 50CC TEMPORARY TOTAL ARTIFICIAL HEART - PEDIATRIC BRIDGE TO TRANSPLANT - PRODUCT DESCRIPTION

The ##-year-old needed a heart transplant, but a matching donor heart wasn t available.

  • Medical Device
  • Orthopedics
  • United States
  • Company
  • CARMAT
  • LIST OF FIGURES

Using the OCS™ technology, the heart transplant team at St.

  • Medical Device
  • United States
  • Company
  • Product Initiative
  • TransMedics, Inc.

ANNOUNCED IT HAS RECEIVED FDA APPROVAL FOR ITS HEARTWARE HVAD SYSTEM AS A DESTINATION THERAPY FOR PATIENTS WITH ADVANCED HEART FAILURE WHO ARE NOT CANDIDATES FOR HEART TRANSPLANTS.

  • Medical Device
  • Vaccine
  • Forecast
  • Market Size
  • Abbott
  • CAREDX INC PIPELINE PRODUCTS AND ONGOING CLINICAL TRIALS OVERVIEW
  • MAR 18, 2018: OLERUP QTYPE NOW AVAILABLE ON APPLIED BIOSYSTEMS PLATFORMS

THE COMPANY OFFERS COMMERCIALIZED TESTING SOLUTION, THE ALLOMAP HEART TRANSPLANT MOLECULAR TEST, IS A NONINVASIVE BLOOD TEST USED WHICH HELPS CLINICIANS TO MONITOR AND IDENTIFY ACUTE CELLULAR REJECTION IN HEART TRANSPLANT RECIPIENTS.

  • Immunology
  • Medical Device
  • Vaccine
  • United States
  • CareDx, Inc.
  • SYNCARDIA SYSTEMS UP FOR SALE
  • PRODUCT NEWS MAR 29, 2017: SYNCARDIA TO HONOR EIGHT LEADING TOTAL ARTIFICIAL HEART HOSPITALS DURING ISHLT

" No one else is doing what they do for heart failure patients, and it' s an honor to join the team.

  • Medical Device
  • Prosthesis
  • United States
  • Corporate Finance
  • SynCardia Systems, Inc.

The prominent features of this report are - ##.

  • Medical Biotechnology
  • Medical Device
  • Targeted Therapy
  • Vaccine
  • World
  • DORMANT PRODUCTS, H2 2018 (CONTD..1), H2 2018

## ## ## Universities/ Institutes ## ## ## ## ## ## PRODUCTS UNDER DEVELOPMENT BY INDICATION NUMBER OF PRODUCTS UNDER DEVELOPMENT BY TOP ## INDICATIONS, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H## 2018 Indication Source: Global Markets Dire

  • Immunology
  • Immunotherapy
  • Medical Device
  • Targeted Therapy
  • Vaccine
  • HEARTWARE VENTRICULAR ASSIST DEVICE - BRIDGE-TO-TRANSPLANT - PRODUCT DESCRIPTION
  • JARVIK 2000 HEART - BRIDGE TO TRANSPLANT - PRODUCT DESCRIPTION

Especially important for heart failure patients is the ability to return home, with their loved ones, as they await heart transplantation.

  • Clinical Trial
  • Hospital
  • Medical Device
  • Pump
  • Vaccine
  • CARDIACSTAR - BRIDGE TO DECISION - PRODUCT DESCRIPTION
  • STREAMLINER VAD - PRODUCT DESCRIPTION

Especially important for heart failure patients is the ability to return home, with their loved ones, as they await heart transplantation.

  • Immunology
  • Medical Device
  • Orthopedics
  • Vaccine
  • United States
  • JARVIK 2000 HEART - BRIDGE TO TRANSPLANT - PRODUCT DESCRIPTION

Especially important for heart failure patients is the ability to return home, with their loved ones, as they await heart transplantation.

  • Assisted Living
  • Clinical Trial
  • Medical Device
  • Orthopedics
  • Vaccine
  • Untitled
  • OPERATIVE CONDITIONS. THESE FACTORS WILL CREATE AMPLE LUCRATIVE OPPORTUNITIES FOR INTRA-AORTIC BALLOON PUMPS IN THIS GEOGRAPHY.

MOST PATIENTS WHO RECEIVE VADS, AND ALL PATIENTS WHO RECEIVE HEART TRANSPLANTS, ARE ELIGIBLE FOR MD-DRG ## REIMBURSEMENT.

  • Medical Device
  • Vaccine
  • World
  • Market Size
  • Abiomed, Inc.

The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients.

  • Immunology
  • Medical Device
  • Targeted Therapy
  • France
  • Diaxonhit
  • US: FLUOROSCOPY EQUIPMENT MARKET FOR SURGICAL APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
  • 8.2 NORTH AMERICA

Moreover, around ## heart transplants are performed in Canada each year.

  • Medical Device
  • Orthopedics
  • North America
  • United States
  • Shimadzu Corporation
  • DIAGNOSTIC TEST - HEART TRANSPLANTATION PRODUCT OVERVIEW

WE ARE ALSO EXCITED ABOUT THE DEMONSTRATED VALUE OF OUR IL-## PLATFORM IN CARDIAC DISEASE.

  • Immunology
  • Medical Device
  • Orthopedics
  • Targeted Therapy
  • Vaccine

The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients.

  • Medical Device
  • Medical Equipment
  • Targeted Therapy
  • United Kingdom
  • Horizon Discovery
  • MAGNETOM AVANTO 1.5T TIM+DOT INTEGRATED - MAGNETIC RESONANCE ELASTOGRAPHY OF CARDIAC TRANSPLANT REJECTION
  • SIEMENS HEALTHCARE GMBH - ONGOING CLINICAL TRIALS OVERVIEW

USING POST-MORTEM BRAIN ANALYSIS, THE RESEARCHERS FOUND THAT THE TRANSPLANTED CELLS GRAFTED AND SURVIVED WELL IN THE TEST ANIMALS AFTER TRANSPLANTATION.

  • Immunology
  • Medical Device
  • Orthopedics
  • Targeted Therapy
  • Vaccine